Outlook Therapeutics Inc (OTLK)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Outlook Therapeutics Inc-Aktie (OTLK)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-30	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8,236% 1.5053	-0.0185	0.0489	-	-
Cost Of Revenue	0.4398	-	-	-	-
Gross Profit	1.0655	-	-	-	-
Operating Expenses	35.89% 16.81	12.37	21.66	-	19.56
Benefits Costs and Expenses	53.26% 21.66	46.34	-17.33	-	-
Costs And Expenses	53.26% 21.66	46.34	-17.33	-	-
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Depreciation and Amortization	0.0294	-	-	0.0288	0.0287
Operating Income/Loss	27.09% -15.75	-12.39	-21.61	-22.88	-19.56
Net Interest Income/Expense	166.73% -0.0494	-0.0185	0.0489	-	-
Interest Income/Expense After Provision For Losses	166.73% -0.0494	-0.0185	0.0489	-	-
Income/Loss Before Equity Method Investments	56.56% -20.12	-46.32	17.41	5.7065	44.47
Income/Loss From Equity Method Investments	15.17% -0.0309	-0.0364	-0.0333	-0.0152	-0.0575
Income/Loss From Continuing Operations Before Tax	56.53% -20.15	-46.35	17.38	5.6913	44.41
Income Tax Expense/Benefit	100.00% -	0.0028	-	-	-
Income/Loss From Continuing Operations After Tax	56.53% -20.15	-46.36	17.38	5.6913	44.41
Net Income/Loss	56.53% -20.15	-46.36	17.38	5.6913	44.41
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	19.70% 36.96	30.87	-3.3567	1.726	23.23
Diluted Average Shares	19.70% 36.96	30.87	-3.3567	1.726	25.48
Basic Earnings Per Share	63.33% -0.55	-1.50	0.45	0.76	1.91
Diluted Earnings Per Share	63.33% -0.55	-1.50	0.45	0.76	-0.89
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%